πŸ‡ΊπŸ‡Έ FDA
Patent

US 10232042

Conjugates of an anti-TNF-alpha antibody

granted A61KA61K2039/6093A61K39/3955

Quick answer

US patent 10232042 (Conjugates of an anti-TNF-alpha antibody) held by Nektar Therapeutics expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/6093, A61K39/3955, A61K39/44, A61K47/60